1. Pharmacokinetic effects of capsaicin on vinblastine in rats mediated by CYP3A and Mrp2
- Author
-
Jun Liu, Yan Zong, Yiming Feng, Shenrong Gao, Zhan Tuo, Jie Li, Yi Lv, and Xuejia Zhai
- Subjects
Male ,CYP3A ,Blotting, Western ,Pharmacology ,Vinblastine ,030226 pharmacology & pharmacy ,Food-Drug Interactions ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Pharmacokinetics ,medicine ,Animals ,Cytochrome P-450 CYP3A ,Pharmacology (medical) ,ATP Binding Cassette Transporter, Subfamily B, Member 1 ,RNA, Messenger ,Reverse Transcriptase Polymerase Chain Reaction ,business.industry ,Alkaloid ,Multidrug resistance-associated protein 2 ,Chronic ingestion ,Multidrug Resistance-Associated Protein 2 ,Rats ,chemistry ,Capsaicin ,Area Under Curve ,Cyclosporine ,Multidrug Resistance-Associated Proteins ,business ,030217 neurology & neurosurgery ,medicine.drug ,Olive oil - Abstract
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide, CAP) is an important ingredient in spicy foods consumed throughout the world. Vinblastine (VBL) is a naturally occurring alkaloid prescribed to cancer patients. Many cancer patients treated with VBL were taking CAP at the same time. This study attempted to investigate the effect of CAP on the pharmacokinetics of VBL, which is the substrate of CYP3A, P-gp, and Mrp2. CAP, cyclosporine (CsA) or olive oil was given to rats for seven consecutive days, and on the seventh day, VBL (1.3 mg/kg) was administered intravenously. CsA was used as a CYP3A1/2 and transporter inhibitor, and olive oil was used as a vehicle. The results showed that pretreatment of rats with CAP (3.0 mg/kg) for seven consecutive days resulted in an increase in the AUC0-t of VBL of about 29.8% (P < 0.05) compared with the control group. Moreover, CAP decreased the CL of VBL to 75.5% (P < 0.05). At this time, CYP3A1/2 and Mrp2/Abcc2 in the liver was decreased at the mRNA and protein levels. These results demonstrate that chronic ingestion of CAP will increase systemic exposure and reduce clearance of VBL in rats. The food-drug interaction between CAP and VBL appears to be due to modulation of CYP3A1/2 and Mpr2 expression by CAP.
- Published
- 2019
- Full Text
- View/download PDF